Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluoHeart: S-1 vs Capecitabine Cardiotoxicity in GI Cancer
NCT02216149Phase 2Terminated
- Start
- Jan 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in adenocarcinoma of the gastrointestinal tract. Started Jan 2015; status: terminated.
02
Drugs
tegafur
03
Conditions
adenocarcinoma of the gastrointestinal tract
Beyond the preview
Go deeper on NCT02216149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216149.